Eva Garland Consulting’s unique expertise in science and finance has supported innovators in leveraging over $2 billion in funding for transformative technologies.
Trending
Upcoming Webinar — SBIR/STTR Reauthorization: What's Changed and How to Prepare
Join EGC’s Dr. Kelsey McLaughlin on Wednesday, May 20th at 1 PM ET / 10 AM PT for insights on the latest SBIR/STTR reauthorization updates and what they mean for small businesses pursuing non-dilutive funding.
EGC's May Newsletter
This month, EGC highlights client Inflammatory Response Research’s $2M CDMRP award to advance a novel trauma therapy. We also cover the latest SBIR/STTR updates across federal agencies and spotlight upcoming funding opportunities from CDMRP, the DoW, NIH, ARPA-H, NASA, and Ed, along with an upcoming webinar on how to navigate the reauthorized SBIR/STTR program.
Read Now — The Latest on SBIR Reauthorization
S. 3971 has been signed into law. This reauthorizes the S. 3971 is now law, officially reauthorizing the SBIR/STTR programs through 2031. Our experts have gathered the latest insights—including agency updates, new regulations, and practical guidance to help you prepare for what’s ahead.
Read Now — How to Protect Your Business from Payment Fraud
Get the latest risk management insights from EGC accounting expert Aron Josefsberg, MBA, as he shares practical strategies to help businesses protect against rising payment fraud threats. In this blog, Aron outlines common red flags, key internal controls, and proactive verification steps organizations can use to prevent email spoofing, fraudulent payment requests, and costly financial losses.
Watch Now — ARPA-H 101: Funding Big Ideas
This webinar, led by scientific grants expert Dr. Chelcie Heaney, provides a practical guide to approaching funding opportunities at ARPA-H. Attendees learn about ARPA‑H’s structure, mission offices, and funding mechanisms like Mission Office Innovative Solution Openings (ISOs) and targeted programs, including the use of Other Transactions (OTs), and gain actionable insights for assessing idea fit, developing solution summaries, and preparing full proposals.
Read Now — Attending ARPA-H BIOGAMI Proposers' Day: What Actually Matters
Get the latest insights from EGC grant writing expert, Mayank Boob, Ph.D., as he reflects on attending Advanced Research Projects Agency for Health (ARPA-H) Proposers’ Day for the BIOGAMI program. In this blog, Mayank shares key takeaways on how ARPA-H evaluates ideas, why in-person engagement and early preparation matter, and how alignment with a Program Manager’s vision can make or break a submission.
Client Highlights
Medgene
Veterinary Diagnostics and Vaccines Company Receives USDA, NIH, and DHA Funding...
TARGAN
NSF Funding and $135M Private Investment Powers Precision Poultry Technology to Transform Global Hatcheries
PediaMetrix
NIH and NSF Funding Powers PediaMetrix's AI-Driven Pediatric Screening Platform...
Crystal Sonic
Solid Financial Foundation Propels Semiconductor Manufacturing Technology...
Minerva Lithium
Minerva Lithium’s Funding Strategy Advances Its Vision for a More Sustainable Energy Supply
DataJoint
A Strategic Funding Roadmap Propels DataJoint’s Leadership in Scientific Workflows...
Ship of Theseus
Rebuilding the Body from Within, Fueled through NIH Funding...
Our Clients Have Secured
$1,991,689,721
In Non-dilutive Funding
“Our team from EGC has been extremely prompt, professional, and knowledgeable. We were considering hiring a part time administrator to help with grants management and book-keeping, but EGC has been able to provide that service with more expertise, and they do so more efficiently. I highly recommend them!”
Brian Lawson, Co-Founder
“Our company exists today because of EGC. As cost intensive as biotech is, and reticent it is to fund new science (unchartered), we’ve had to rely on any and every resource available to keep WinSanTor alive. We are now about to enter phase 3 as the first and only company regrowing and repairing peripheral nerve damage (aka peripheral neuropathy), and Eva and her team were there every step of the way. They helped us turn over every rock, and with their help, we’ve received tens of millions of dollars of funding that literally kept the company afloat. They have an amazing team, which we now consider part of our own company as far as desire and commitment.”
Stanley Kim, Co-Founder & CEO
“Working with EGC team has been critical in identifying and applying for non-dilutive grant opportunities. The team has done all the heavy lifting while helping to navigate the application process, optimizing the project rationales and providing all the help we need to navigate towards success. I would highly recommend the EGC work if you are looking to submit successful applications across all relevant funding bodies.”
Mitch Raponi, Co-Founder & CEO
“I have used EGC for 4 years now and I continue to be impressed with their team and the product offerings that come with their engagements. We began using some of their grant budget consulting this year and I am so impressed!”
Alli Truttmann, CEO
“Lu Lu has been a pleasure to work with. She is insightful and understood our technology and business plans well. I think she’s drafted an excellent strategic plan for us to pursue non-dilutive funding opportunities.”
Michael Emanuel, Founder & CEO
“I have the utmost respect for the professionalism and hard work displayed by my team at EGC. They are fantastic!”































































